Credit Suisse plans 6.25% contingent coupon autocallable reverse convertibles tied to Amgen

New York, May 10 – Credit Suisse AG, London Branch plans to price 6.25% contingent coupon autocallable reverse convertible securities due Aug. 27, 2018 linked to the common stock of Amgen Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The contingent 6.25% coupon is payable quarterly if the closing level of Amgen stock is below 75% of its initial level on the observation date for that quarter.

The notes will be automatically called at par if Amgen shares close at or above their initial price on Nov. 21, 2017, Feb. 21, 2018 or May 23, 2018.

The payout at maturity will be par unless Amgen stock closes at or below the knock-in price, 75% of the initial share price, on any day during the life of the notes and finishes below the initial share price, in which case investors will receive a number of Amgen shares equal to $1,000 divided by the initial share price or, at the issuer’s option, the cash equivalent.

Credit Suisse Securities (USA) LLC is the agent.

The notes will price on May 23 and settle on May 26.

The Cusip number is 22549JGT1.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.